Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion type Assertion NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_head.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion description "[Consistently, GR expression was found in a high percentage of oesophageal squamous cell carcinomas (SCC) (98.1%) and hepatocellular carcinomas (HCC) (92.9%), but rarely in gastric adenocarcinomas (7.4%) and not at all in colorectal adenocarcinomas (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_provenance.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion evidence source_evidence_literature NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_provenance.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion SIO_000772 18269582 NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_provenance.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion wasDerivedFrom befree-2016 NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_provenance.
- NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_assertion wasGeneratedBy ECO_0000203 NP655058.RAqfv7CYx559x93lnLaiQNwk-Sr2E5oi24ZTcCU98GHXk130_provenance.